RUNX2 Gene Cleidocranial Dysplasia Genetic Test
At DNA Labs UAE, we offer the RUNX2 Gene Cleidocranial Dysplasia Genetic Test. This test is designed to analyze the DNA sequence of the RUNX2 gene and detect any mutations or variations that may be present. Cleidocranial dysplasia (CCD) is a rare genetic disorder that affects the development of bones and teeth, and the RUNX2 gene is associated with this condition.
Test Components and Price
The price for the RUNX2 Gene Cleidocranial Dysplasia Genetic Test is 4400.0 AED. The test can be performed using blood or extracted DNA samples, or even just one drop of blood on an FTA card.
Report Delivery and Method
After the test is conducted, the report will be delivered within 3 to 4 weeks. We utilize Next-generation sequencing (NGS) technology for this genetic test. NGS allows for the rapid and cost-effective sequencing of large portions of the genome, making it an efficient tool for genetic testing.
Test Type and Doctor
The RUNX2 Gene Cleidocranial Dysplasia Genetic Test falls under the category of Osteology, Dermatology, and Immunology Disorders. The test is recommended to be conducted by a Dermatologist. The test is performed in our Genetics department.
Pre Test Information
Prior to the test, it is important to provide the clinical history of the patient who is going for the RUNX2 Gene Cleidocranial Dysplasia NGS Genetic DNA Test. Additionally, a Genetic Counselling session will be conducted to draw a pedigree chart of family members affected with the RUNX2 Gene Cleidocranial Dysplasia NGS Genetic DNA Test gene (RUNX2).
Test Details
The RUNX2 gene is associated with cleidocranial dysplasia (CCD), a rare genetic disorder that affects the development of bones and teeth. Next-generation sequencing (NGS) is a genetic test that can be used to analyze the DNA sequence of the RUNX2 gene and detect any mutations or variations that may be present. By performing an NGS genetic test for CCD, healthcare professionals can confirm a diagnosis, provide genetic counseling, and guide treatment options for individuals with the condition. This test can also be used for carrier screening in families with a history of CCD, allowing for early detection and prevention of the disorder in future generations.
Test Name | RUNX2 Gene Cleidocranial dysplasia Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Osteology Dermatology Immunology Disorders |
Doctor | Dermatologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for RUNX2 Gene Cleidocranial dysplasia NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with RUNX2 Gene Cleidocranial dysplasia NGS Genetic DNA Test gene RUNX2 |
Test Details |
The RUNX2 gene is associated with cleidocranial dysplasia (CCD), a rare genetic disorder that affects the development of bones and teeth. Next-generation sequencing (NGS) is a genetic test that can be used to analyze the DNA sequence of the RUNX2 gene and detect any mutations or variations that may be present. NGS allows for the rapid and cost-effective sequencing of large portions of the genome, making it a valuable tool for genetic testing. In the case of CCD, NGS can identify specific mutations in the RUNX2 gene that are known to be associated with the disorder. By performing an NGS genetic test for CCD, healthcare professionals can confirm a diagnosis, provide genetic counseling, and guide treatment options for individuals with the condition. Additionally, this test can also be used for carrier screening in families with a history of CCD, allowing for early detection and prevention of the disorder in future generations. |